James Sublett, MD
Allergy & Immunology · Louisville, KYNPI 1255474136
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $354,674 of the $588,017 with a category attached, or 60.3%. 38 manufacturers reported payments, led by AstraZeneca at 27.8% of the total. Among allergy & immunology clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 783 payments — averaging $750.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$163K
- Sanofi$135K
- Regeneron Healthcare Solutions, Inc.$82K
- Genentech USA, Inc.$38K
- Incyte Corporation$28K
- Kaleo, Inc.$24K
- plus $118K from 32 others
Across 154 payments — averaging $7464.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$404K
- Biocryst Pharmaceuticals, Inc.$271K
- Amgen$100K
- Novartis$88K
- LEO Pharma AS$74K
- Octapharma USA, Inc.$57K
- plus $155K from 9 others
What the payments were for
- Consulting fees$172,63129%
- Speaking & faculty fees$354,67460%
- Grants$2,7000%
- Travel & lodging$38,1796%
- Food & beverage$19,8333%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 206 | $163,326 |
| Sanofi | 100 | $135,069 |
| Regeneron Healthcare Solutions, Inc. | 121 | $82,050 |
| Genentech USA, Inc. | 66 | $37,557 |
| Incyte Corporation | 16 | $28,014 |
| Kaleo, Inc. | 25 | $23,668 |
| Dermavant Sciences, Inc. | 20 | $19,486 |
| Amgen | 31 | $17,739 |
| Ionis Pharmaceuticals, Inc. | 14 | $16,672 |
| Optinose US, Inc. | 31 | $15,638 |
| Aimmune Therapeutics, Inc. | 3 | $11,888 |
| Organon | 7 | $8,367 |
| Jubilant Hollisterstier LLC | 1 | $5,899 |
| Merz Pharmaceuticals, LLC | 2 | $5,660 |
| Pfizer | 11 | $5,111 |
| Hikma Pharmaceuticals USA | 3 | $4,345 |
| Alk-abello, Inc | 10 | $2,501 |
| Aquestive Therapeutics, Inc. | 2 | $2,293 |
| Novartis | 12 | $700 |
| GSK | 28 | $495 |
| CSL Behring | 20 | $400 |
| Teva Pharmaceuticals USA, Inc. | 20 | $291 |
| Genentech, Inc. | 2 | $128 |
| Sanofi-aventis U.S. LLC | 3 | $112 |
| Blueprint Medicines Corporation | 3 | $106 |
| Pharming Healthcare, Inc. | 5 | $98 |
| Octapharma USA, Inc. | 3 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| Boehringer Ingelheim | 4 | $54 |
| Lilly USA, LLC | 2 | $37 |
| Grifols USA, LLC | 2 | $29 |
| Seqirus USA Inc | 1 | $27 |
| PARI Respiratory Equipment, Inc. | 1 | $27 |
| LEO Pharma Inc. | 1 | $26 |
| Cycle Pharmaceuticals Inc | 1 | $23 |
| AbbVie | 1 | $19 |
| Merck | 1 | $18 |
| Aytu Biopharma, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$588,017 in reported general payments places this provider in the 95th percentile of 66 allergy & immunology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 53 | $48,078 |
| Breo ElliptaFluticasone/Vilanterol | 35 | $15,898 |
| Epinephrine | 60 | $14,708 |
| Spiriva RespimatTiotropium Bromide | 13 | $8,889 |
| DuleraMometasone/Formoterol | 12 | $8,869 |
| SymbicortBudesonide/Formoterol Fumarate | 18 | $7,207 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 11 | $5,180 |
| Advair HfaFluticasone Propion/Salmeterol | 12 | $3,698 |
| Azelastine Hcl | 129 | $3,365 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 11 | $3,219 |
| BreynaBudesonide/Formoterol Fumarate | 24 | $2,905 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 65 | $2,363 |
| Fluticasone Propionate | 173 | $2,215 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 16 | $1,327 |
| Ipratropium Bromide | 43 | $1,261 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $495 | $63,97588 claims |
| Hikma Pharmaceuticals USAEpinephrine | $4,345 | $14,70860 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat | $54 | $14,06924 claims |
| MerckDulera | $18 | $8,86912 claims |
| AstraZenecaSymbicort | $163,326 | $7,20718 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 66 allergy & immunology providers in Kentucky.
Other allergy & immunology in Louisville
- Stephen PollardLouisville$301K
- Douglas LotzLouisville$199K
- James SublettLouisville$194K
- Timothy FranxmanLouisville$162K
- Jeremy JonesLouisville$149K
- Mark CorbettLouisville$138K
- Kali GeraceLouisville$29K
- David PallaresLouisville$22K
- Joseph TurbyvilleLouisville$13K
- Stuart WhiteLouisville$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.